Omnipulse Biosciences
Omnipulse Biosciences is a startup headquartered in Cambridge, United States, founded in 2022. It has raised at least $7.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Omnipulse Biosciences has raised at least $7.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Omnipulse Biosciences sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Cambridge
- 2Pi
- Acceleron Fusion
- actnano
- AIScientists
- Apeiron Labs
- Aptamino
- Arches Medical Independents
- Aviceda Therapeutics
- Axoft
- Blitzy
- Caldera Therapeutics
Related
- Innovation profile of Cambridge
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Omnipulse Biosciences do?
Omnipulse Biosciences is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Omnipulse Biosciences raised?
At least $7.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Omnipulse Biosciences based?
Omnipulse Biosciences is headquartered in Cambridge, United States.
When was Omnipulse Biosciences founded?
Omnipulse Biosciences was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.